Title : Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.

Pub. Date : 2016 May 26

PMID : 27111731






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Preclinical Characterization of 3beta-(N-Acetyl l-cysteine methyl ester)-2abeta,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer. 3beta-(n-acetyl l-cysteine methyl ester)-2abeta signal transducer and activator of transcription 3 Mus musculus